Earlier this month, Brook Baker posted a Civil Society Statement in support of an upcoming Brazilian legislative proposal that would make greater use of TRIPS flexibilities to promote access to medicines. The legislation will be introduced in August and it will “eliminate patent term extensions and data exclusivity, restrict patents on new forms and new uses and tighten the the inventive step requirement (following the India example), adopt government use procedures, and clarify the role that ANVISA, its drug regulatory agency, plays in the patent examination system.”
The statement is open for endorsement from civil society groups. Marcela Vieira from the Brazilian Interdisciplinary Aids Association has translated the statement into both Spanish and Portuguese. The full statement in English, Spanish and Portuguese, and a short form for institutional endorsements are available here.
In addition to the Civil Society Statement, there is a sign-on letter for academics that is also open for signature. The academics letter is available here.
QUT Media4th November 2025 The United Kingdom Parliament is considering a bill aimed at making smoking obsolete, which has been
Speaking at the Global Expert Network on Copyright User Rights Symposium on 16 June 2025, Professor Christophe Geiger argues for
On 25 September 2025, Professor Wend Wendland, delivered the 14th Peter Jaszi Distinguished Lecture at American University in Washington D.C..
On September 18, 2025, the Italian Senate definitively approved the country’s first comprehensive framework law on artificial intelligence (AI). The
Por Andrés Izquierdo Durante la segunda semana de agosto, fui invitado a hablar en la Feria Internacional del Libro de
By Andrés Izquierdo AI, Copyright, and the Future of Creativity: Notes from the Panama International Book FairDuring the second week